EP1802329
A PHARMACEUTICAL FORMULATION COMPRISING CRYSTALLINE INSULIN AND DISSOLVED INSULIN
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.10.2005EP published:
6.5.2015EP application number:
05792052.2
EPO information:
European Patent Register
Max expiry date:
4.10.2025
Title:
A PHARMACEUTICAL FORMULATION COMPRISING CRYSTALLINE INSULIN AND DISSOLVED INSULIN
Timeline
Today
5.10.2005EP application
6.5.2015EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880, Bagsværd, DK
Inventor
Name:
BERGLUND, PetterAddress:
S-226 49 Lund, SE
Name:
HAMMELEV, CharlotteAddress:
Farum, DK
Name:
ESKILDSEN, LoneAddress:
Slangerup, DK
Name:
MADSEN, JohanneAddress:
Lyngby, DK
Name:
OLSEN, Helle, AalundAddress:
Måløv, DK
Name:
KIMER, Lone, LøgstrupAddress:
Farum, DK
Priority
Number:
200401519Date:
5.10.2004Country:
DK
Classification
Categories:
A61K 38/28, A61P 3/10